Kailera Therapeutics
Waltham, United States · Founded 2024 · $1.0B raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- kailera.com
- Total Funding
- $1.0B
- Last Round
- $600.0M Series BOct 2025
- Rounds
- 2
About
Clinical-stage biotech developing next-generation GLP-1/GIP dual agonist therapies for obesity
Summary
Kailera Therapeutics is a Biotech company based in Waltham, United States, founded in 2024. It has raised $1.0B in total across 2 rounds, most recently a $600.0M Series B round in Oct 2025.
Tech & App Stack
7 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...